Motilal Oswal BSE Healthcare ETF - Growth - Regular Plan

  • Previous Nav

  • Net Change on 17-03-2026

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Nifty 50 ETF Jul 22, 2015 5.63 12.50 10.65 0.04 213,394.34
SBI BSE SENSEX ETF Mar 15, 2013 3.37 10.67 9.83 0.04 121,592.96
UTI Nifty 50 ETF Sep 01, 2015 5.66 12.52 10.66 0.05 69,057.50
Nippon India ETF Nifty 50 BeES Dec 28, 2001 5.64 12.52 10.67 0.04 57,632.90
UTI BSE Sensex ETF Sep 01, 2015 3.39 10.68 9.65 0.05 53,583.43

Fund Holdings as on 28-February-2026

  • Sun Pharmaceutical Industries Limited

  • Divi's Laboratories Limited

  • Max Healthcare Institute Limited

  • Apollo Hospitals Enterprise Limited

  • Dr. Reddy's Laboratories Limited

  • Cipla Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Torrent Pharmaceuticals Limited

  • Laurus Labs Limited

  • Aurobindo Pharma Limited

  • Alkem Laboratories Limited

  • Glenmark Pharmaceuticals Limited

  • Biocon Limited

  • Mankind Pharma Limited

  • Zydus Lifesciences Limited

  • IPCA Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Aster DM Healthcare Limited

  • Gland Pharma Limited

  • Abbott India Limited

  • Sai Life Sciences Limited

  • Ajanta Pharma Limited

  • Narayana Hrudayalaya Limited

  • Wockhardt Limited

  • Acutaas Chemicals Limited

  • Neuland Laboratories Limited

  • Dr. Lal Path Labs Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Piramal Pharma Limited

  • Global Health Limited

  • Natco Pharma Limited

  • Granules India Limited

  • Syngene International Limited

  • Pfizer Limited

  • Onesource Specialty Pharma Limited

  • Jubilant Pharmova Limited

  • Dr Agarwals Health Care Limited

  • Rainbow Childrens Medicare Limited

  • Strides Pharma Science Limited

  • Eris Lifesciences Limited

  • AstraZeneca Pharma India Limited

  • Indegene Limited

  • Cohance Lifesciences Limited

  • Metropolis Healthcare Limited

  • Poly Medicure Limited

  • Vijaya Diagnostic Centre Limited

  • Jupiter Life Line Hospitals Limited

  • Emcure Pharmaceuticals Limited

  • Concord Biotech Limited

  • Alembic Pharmaceuticals Limited

  • Procter & Gamble Health Limited

  • Aarti Pharmalabs Limited

  • Marksans Pharma Limited

  • Shilpa Medicare Limited

  • Sanofi India Limited

  • Caplin Point Laboratories Limited

  • Sanofi Consumer Healthcare India Limited

  • Healthcare Global Enterprises Limited

  • Alivus Life Sciences Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • Viyash Scientific Limited

  • Kovai Medical Center and Hospital Limited

  • Net Receivables / (Payables)

  • Senores Pharmaceuticals Limited

  • Thyrocare Technologies Limited

  • Indraprastha Medical Corporation Limited

  • FDC Limited

  • Supriya Lifescience Limited

  • Morepen Laboratories Limited

  • Advanced Enzyme Technologies Limited

  • Blue Jet Healthcare Ltd

  • Bliss GVS Pharma Limited

  • Solara Active Pharma Sciences Limited

  • Aarti Drugs Limited

  • Akums Drugs and Pharmaceuticals Limited

  • Sun Pharma Advanced Research Company Limited

  • Krsnaa Diagnostics Limited

  • Dishman Carbogen Amcis Limited

  • SMS Pharmaceuticals Limited

  • Innova Captab Limited

  • Gujarat Themis Biosyn Limited

  • Orchid Pharma Limited

  • Suven Life Sciences Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • RPG Life Sciences Limited

  • Gufic Biosciences Limited

  • Indoco Remedies Limited

  • Hikal Limited

  • Kwality Pharmaceuticals Limited

  • Unichem Laboratories Limited

  • Artemis Medicare Services Limited

  • Vimta Labs Limited

  • 3B BlackBio Dx Limited

  • Lincoln Pharmaceuticals Limited

  • Windlas Biotech Limited

  • Novartis India Limited

  • Hester Biosciences Limited

  • Syncom Formulations India Limited

  • Dr.Agarwals Eye Hospital Limited

  • Panacea Biotec Limited

  • Suraksha Diagnostic Limited

  • Wanbury Limited

  • Fischer Medical Ventures Limited

  • Bajaj Healthcare Limited

  • Shalby Limited

  • Sigachi Industries Limited

  • Laxmi Dental Limited

  • Kopran Limited

  • GPT Healthcare Limited

  • KMC Speciality Hospitals (India) Limited

  • Fermenta Biotech Limited

  • Jagsonpal Pharmaceuticals Limited

  • Tarsons Products Limited

  • Themis Medicare Limited

  • Sastasundar Ventures Limited

  • Anuh Pharma Limited

  • Shree Ganesh Remedies Limited

  • Nectar Lifesciences Limited

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

  • Trading

  • Plastic Products

  • Finance - NBFC

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal BSE Healthcare ETF

Scheme Analysis

Motilal Oswal BSE Healthcare ETF is a ETFs - Index fund and belongs to Motilal Oswal Mutual Fund. It was launched on 29-Jul-2022 and currently has an AUM of ₹42.77 crore. Motilal Oswal BSE Healthcare ETF is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Motilal Oswal BSE Healthcare ETF ended up ₹0.18(0.43%)yesterday to ₹43.026.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Motilal Oswal BSE Healthcare ETF is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022 40548002
amc@motilaloswal.com
022-22816161